NCT04330755View on ClinicalTrials.gov

Levosimendan Versus Combination With Magnesium Sulphate on Spine Protection by NIRS in Infants Undergoing Coarctectomy

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 4, 2021

Primary Completion Date

March 30, 2023

Study Completion Date

April 30, 2023

Conditions

Aortic Coarctation

Interventions

DRUG

Saline Solution

Placebo

DRUG

Levosimendan

DRUG

Magnesium Sulfate

Trial Locations (1)

12555

Sara ABD El-Salam, Cairo

All Listed Sponsors

collaborator

Cairo University

OTHER

lead

Dalia Saad Abd-El Kader

OTHER

NCT04330755 - Levosimendan Versus Combination With Magnesium Sulphate on Spine Protection by NIRS in Infants Undergoing Coarctectomy | Biotech Hunter | Biotech Hunter